Answers are grounded in this paper and cite their sources.
The World Health Organization African Region carries the greatest global malaria burden. Disaggregated comparisons of caregiver-reported malaria diagnostic testing across sources of fever care can help identify service-delivery gaps. We analyzed WHO-calculated estimates from the World Malaria Report 2025, Annex 4Cb, for 25 Demographic and Health Surveys (DHS) or Malaria Indicator Surveys (MIS) conducted between 2017 and 2023. The outcome was the estimated percentage of children younger than 5 years with caregiver-reported fever in the preceding two weeks among those for whom care was sought from a given provider category, whose caregiver reported a diagnostic blood test (finger/heel prick). The survey test question was not attributed directly to a particular provider; the WHO associated reported testing with reported care sources. We compared country-survey percentages for formal private medical care, pharmacies/accredited drug stores, and informal private care against public care, excluding community health workers (CHWs). Within-country differences were summarized by medians, 100,000-resample bootstrap intervals, and paired Wilcoxon tests with Holm adjustment for diagnostic contrasts. Across 25 country-surveys (16 DHS; 9 MIS), median caregiver-reported diagnostic testing estimates were 64% in public care (quartiles 52–78), 51% in formal private care (30–58), 14.5% in pharmacies/drug stores (7.2–18.2; n = 22), and 8% in informal private care (4–11.8; n = 24). Median paired differences relative to public care were −5 percentage points (95% bootstrap interval −22 to 0; adjusted P = 0.004), −48 (−55 to −39; adjusted P < 0.001), and −49 (−58 to −45; adjusted P < 0.001), respectively. Differences varied substantially across countries, with formal-private testing exceeding public estimates in six countries. Survey-derived testing estimates were substantially lower in the retail and informal care categories than in public care, but provider-associated testing cannot be equated with testing performed at a given outlet. Country-specific regulatory, affordability, and supply-chain information is needed before inferring mechanisms or choosing interventions.
No takes yet. Share an insight, caveat, or question.
Yosef et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: